Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination

QR Code

Targeting the Minimal Residual Disease in Acute Myeloid Leukemia: The Role of Adoptive Immunotherapy with Natural Killer Cells and Antigen-Specific Vaccination

None

Saved in:

Bibliographic Details
Main Authors:	Parisi, Sarah, Curti, Antonio
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/31173
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Functional features of natural killer cells in acute myeloid leukemia
by: K. A. Nikiforova, et al.
Published: (2023-12-01)

Recurrence of minimal residual disease in acute myeloid leukemia: a window of opportunity for intervention
by: Aniket Bankar
Published: (2025-07-01)

NK cell-based immunotherapy strategies for myeloid leukemia
by: Lin Zhang, et al.
Published: (2025-07-01)

MINIMAL RESIDUAL DISEASE ASSESMENT IN PATIENTS WITH ACUTE MYELOID LEUKEMIA BY MULTICOLOUR FLOW CYTOMETRY (LITERATURE REVIEW)
by: T. I. Lobanova, et al.
Published: (2018-05-01)

Natural killer cels in immunotherapy for cancer
by: E. A. Borobova, et al.
Published: (2019-01-01)

Usage of IFNγ or TNFα-T in protocols for obtaining cytokine-induced killer cells for adoptive immunotherapy
by: Yu. V. Gelm, et al.
Published: (2025-03-01)

The Proteasome as a Therapeutic Target in Chronic Myeloid Leukemia
by: Pérez-Roger, Ignacio, et al.
Published: (2011)

Neo-antigen specific cancer vaccines for acute lymphoblastic leukemia—challenges, opportunities, and future directions
by: Victoria Bloch Blytt Sandstad, et al.
Published: (2025-06-01)

Expansion of cancer germline antigen–specific cytotoxic T lymphocytes for immunotherapy
by: Deepa Kolaseri Krishnadas, et al.
Published: (2017-07-01)

DISTRIBUTION PATTERN FOR HLA SPECIFICITIES IN THE PATIENTS WITH ACUTE MYELOID LEUKEMIA
by: I. R. Ramilyeva, et al.
Published: (2019-12-01)

Licensed to Kill: Towards Natural Killer Cell Immunotherapy
by: Eissens, Diana N., et al.
Published: (2012)

Pharmacoeconomic modeling of target therapy of chronic myeloid leukemia in remission
by: V. A. Shuvaev, et al.
Published: (2015-01-01)

Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target
by: Mengnan Liu, et al.
Published: (2025-07-01)

Autotransplantation of T-lymphocytes as a tool for antigen-specific immunotherapy of oncological diseases
by: A. Yu. Lupatov, et al.
Published: (2018-09-01)

Adoptive immunotherapy with interleukin-2 and lymphokine-activated killers in patients with malignant neoplasms of the female reproductive system (a review of literature)
by: A. N. Gritsai, et al.
Published: (2015-01-01)

Applications of machine learning for immunophenotypic measurable residual disease assessment in acute myeloid leukemia
by: Tim R. Mocking, et al.
Published: (2025-05-01)

ALLERGEN-SPECIFIC IMMUNOTHERAPY: VACCINES FOR ALLERGIC DISEASES
by: A. S. Fedorov, et al.
Published: (2015-10-01)

Engineered red blood cell extracellular vesicles for delivery of Dox and siIDO1 enhance targeted chemo-immunotherapy of acute myeloid leukemia
by: Jing Yang, et al.
Published: (2025-07-01)

Natural Killer Cell Leukemia: Diagnosis, Pathogenesis and Treatment
by: Kobayashi, Shoko
Published: (2011)

Ferroptosis determinants – potential predictors and therapeutic targets for acute myeloid leukemia
by: V. E. Shevchenko, et al.
Published: (2025-06-01)

Methodological aspects of diagnostics and minimal residual disease monitoring in infant acute leukemias
by: G. A. Tsaur, et al.
Published: (2016-03-01)

Therapy of Acute Myeloid Leukemia
by: El-Cheikh, Jean, et al.
Published: (2012)

Pediatric Acute Myeloid Leukemia
by: Zwaan, C. Michel, et al.
Published: (2011)

Methods of molecular biology for detection of genetic aberrations and monitoring of residual disease in acute myeloid leukemia
by: I. A. Demidova
Published: (2022-11-01)

Pediatric acute lymphoblastic leukemia treatment protocols improvement: emphasis on minimal residual disease
by: M. A. Shervashidze, et al.
Published: (2020-10-01)

CANCER TESTIS ANTIGENS IN CANCER IMMUNOTHERAPY
by: D. I. Vodolazhsky, et al.
Published: (2017-06-01)

Vitamin D and Acute Myeloid Leukemia
by: Lee, Hun Ju, et al.
Published: (2011)

Apoptosis and Apoptosis Modulators in Myeloid Leukemia
by: Abdullah, Maha, et al.
Published: (2011)

Clonal hematopoiesis and acute myeloid leukemia
by: A. I. Kashlakova, et al.
Published: (2023-09-01)

Treatment of acute myeloid leukemia in children
by: A. V. Popa, et al.
Published: (2022-11-01)

Gut Microbiome as a Potential Marker of Hematologic Recovery Following Induction Therapy in Acute Myeloid Leukemia Patients
by: Valentina Salvestrini, et al.
Published: (2025-02-01)

Minimal residual disease and outcomes of allogeneic hematopoietic stem cell transplantation in patients with acute leukemia
by: I. V. Galtseva, et al.
Published: (2024-12-01)

Immunotherapies and Vaccines
by: Eugene, Hermancia S., et al.
Published: (2011)

Metabolic aspects of adoptive immunotherapy of tumors
by: D. B. Kazanskiy, et al.
Published: (2017-10-01)

Myeloid/natural killer cell precursor acute leukaemia. Case report and literature review
by: V. R. Gorodetsky, et al.
Published: (2022-11-01)

Checkpoint immunotherapy is associated with preferential activation of tumor antigen–specific CD4+ T cells in MDS
by: Elizabeth A. Griffiths, et al.
Published: (2025-08-01)

The clinical utility and prognostic value of next-generation sequencing for measurable residual disease assessment in acute myeloid leukemia
by: Yu Liu, et al.
Published: (2025-06-01)

ACUTE MYELOID LEUKEMIA PRESENTING AS ISOLATED MYELOID SARCOMA: A CASE REPORT
by: Elif Canpolat Hırfanoğlu, et al.
Published: (2025-07-01)

Targeting the Chronic Myeloid Leukemia Stem Cell: A Paradigm for the Curative Treatment of Human Malignancies
by: Woolfson, Adrian, et al.
Published: (2011)

New Molecular Markers in Acute Myeloid Leukemia
by: Iñigo, Silvia de la Iglesia, et al.
Published: (2011)